DVI News and Events

December 28,  2015
first country in South America to authorize marketing for dengue vaccine

Following the Mexican government’s approval of Dengvaxia® on December 11 and the Philippines's on December 22 for people aged 9 -45 years living in dengue endemic areas.

2012 Year in Review

With the end of 2012 and the start of a new year, we wanted to take this opportunity to review the progress that has been made in heightening public awareness and political will around dengue vaccines, and in progress toward dengue vaccine development, including the first Phase 2 clinical trial results for a dengue vaccine candidate.

The Review discusses highlights of DVI activities and major dengue news from the year. Read the full review here.